CAS: 508-52-1; Ouabagenin

该化合物是一种该化合物是一种自然形成的心律甘蓝,是合成苏巴因和相关化合物的关键中间体,众所周知,这些化合物能够抑制纳加/K+-ATPase,这是细胞离子软体中的一种关键酶.Ouabagenin广泛用于药物学研究,研究心脏液态机制,离子传输调节以及心脏衰竭和高血压的潜在治疗应用.其高纯度和结构特性高,对生物化学实验和结构活动关系研究很有价值.该化合物通常作为白色晶状粉供应,确保实验再生的一致性.

结构式图片

欧盟法规

ECHA物质C&L通报

上下游产品

CAS号1178-61-6 4-((3R,3aR,5R,5... | CAS号275800-73-2 1,19-acetonide-... | CAS号1018988-59-4 (3R,5R,8R,9S,10... | CAS号1018988-44-7 (1R,3R,5R,8R,9S... | CAS号1418284-06-6 4-((2aR,2bS,5R,... | CAS号1018988-61-8

合成工艺路线路线简述

    📜G毒毛旋花苷置于咪唑,盐酸体系中,用 甲醇,N,N-二甲基甲酰胺,乙腈 作为反应溶剂,化学反应 16.0H,反应生成 烏巴配基
    参考文献:Investigations Directed At The Total Synthesis Of Ouabain. Lessons Learned Fromdegradation Studies
    标题:Investigations Directed At The Total Synthesis Of Ouabain. Lessons Learned Fromdegradation Studies
    摘要:
    DOI:10.3987/com-99-S142

    海关参考信息

    专利信息


    专利号:US-2022162188-A1
    优先权日:2019-01-15
    标 题:Isoprenoids and methods of making thereof
    发明人:WILLIAMS GAVIN; LUND SEAN; HALL RACHAEL
    权利人:UNIV NORTH CAROLINA STATE
    摘要:Disclosed are methods for preparing isoprenoid subunits, as well as methods of employing these isoprenoid subunits for the synthesis of isoprenoids. Also provided are isoprenoids prepared using the methods described herein.

    专利号:EP-3004036-A1
    优先权日:2013-05-31
    标题 :Methods of synthesis of ingenol and intermediates thereof

    专利号:CA-2911960-A1
    优先权日:2013-05-31
    标题 :Methods of synthesis of ingenol and intermediates thereof

    专利号:US-6699676-B1
    优先权日:1999-06-03
    标题:Uses of ouabain and ouabain-like molecules in apoptosis related pathologies
    发明人:ORLOV SERGEI N; HAMET PAVEL; TREMBLAY JOHANNE
    权利人:CORP DU CT DE RECH DU CT HOSPI
    摘要:Longterm elevation of the intracellular Na + /K + ratio inhibits macromolecule synthesis and proliferation in the majority of cell types studied so far, including vascular smooth muscle cells (VSMC). We report here that inhibition of the Na + ,K + pump in VSMC by ouabain or 1 hour preincubation in K + -depleted medium attenuated apoptosis triggered by serum withdrawal, staurosporine or okadaic acid. In the absence of ouabain, both DNA degradation and caspase-3 activation in VSMC undergoing apoptosis were insensitive to modification of the extracellular Na + /K + ratio as well as to hyperosmotic cell shrinkage. In contrast, protection of VSMC from apoptosis by ouabain was abolished under equimolar substitution of Na + o with K + o , showing that the anti apoptotic action of Na + ,K + pump inhibition was caused by inversion of the intracellular Na + /K + ratio. Unlike VSMC, the same level of increment of the [Na + ] i /[K + ] i ratio caused by 2 hours preincubation of Jurkat cells with ouabain did not affect chromatin cleavage and caspase-3 activity triggered by treatment with Fas ligand, staurosporine or hyperosmotic shrinkage. Thus, our results show for the first time that similarly to cell proliferation, maintenance of a physiologically low intracellular Na + /K + ratio is required for progression of VSMC apoptosis.

    专利号:CA-2418458-A1
    优先权日:2003-02-06
    标题:Total synthesis of 14 beta-fluorosteroids via the transannular diels-alder reaction

    专利号:AU-2014273108-A1
    优先权日:2013-05-31
    标 题:Methods of synthesis of ingenol and intermediates thereof

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1016/0969-8051(95)02036-5
    摘要:Chatterjee M, Ganguly S, Sarkar BR, Banerjee S. Technetium-99m radiolabeled ouabagenin-cysteine conjugate: Biological evaluation in animal models. Nuclear Medicine and Biology. 1996 Feb;23(2):115–20. doi: 10.1016/0969-8051(95)02036-5.
    参考文献:10.1097/00005344-199312000-00030|10.1097/00005344-199322002-00033
    摘要:Lichtstein D, Gati I, Ovadia H. Digitalis-like compounds in the toad Bufo viridis: interactions with plasma proteins. J Cardiovasc Pharmacol. 1993;22 Suppl 2():S102–5. doi: 10.1097/00005344-199322002-00033.
    参考文献:10.1021/jm0102811
    摘要:Farr CD, Tabet MR, Ball WJ, Fishwild DM, Wang X, Nair AC, Welsh WJ. Three-dimensional quantitative structure-activity relationship analysis of ligand binding to human sequence antidigoxin monoclonal antibodies using comparative molecular field analysis. J Med Chem. 2002 Jul 18;45(15):3257–70. doi: 10.1021/jm0102811.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知